Rigel Pharmaceuticals's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Rigel Pharmaceuticals (NASDAQ:RIGL) is set to release its latest quarterly earnings report on November 7, 2023. Analysts estimate an earnings per share (EPS) of $-0.07. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $0.8811 and has seen a 15.26% increase over the last 52-week period.
November 06, 2023 | 8:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Rigel Pharmaceuticals is expected to report an EPS of $-0.07 in its upcoming earnings. The company's past earnings have shown a mixed impact on the stock price. The stock has seen a 15.26% increase over the last 52 weeks.
The upcoming earnings report is a significant event for Rigel Pharmaceuticals. While the estimated EPS is negative, the company's past performance shows that earnings reports can have a mixed impact on the stock price. Given the stock's positive performance over the last 52 weeks, investors may remain optimistic.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100